Lactobacillus plantarum BFA-LA04 strain with uric acid reducing capacity and application thereof
A BFA-LA04, Lactobacillus germinal technology, applied in medical preparations containing active ingredients, bacteria, microorganism-based methods, etc., can solve problems such as probenecid ineffectiveness, uric acid nephropathy, adverse drug reactions, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0021] In order to make the above-mentioned and other objects, features and advantages of the present invention more comprehensible, the preferred embodiments of the present invention are listed below, together with the accompanying drawings, as follows:
[0022] The Lactobacillus plantarum BFA-LA04 strain of the present invention can decompose xanthine, and can also inhibit the activity of xanthine oxidase, thereby inhibiting the generation of uric acid, so it can be used as a drug for hyperuricemia.
[0023] The Lactobacillus plantarum BFA-LA04 strain is obtained from muskmelon fruit. Specifically, after the muskmelon fruit is squeezed, the muskmelon fruit juice is coated on MRS solid medium containing calcium carbonate (the formula is shown in Table 1. ), after selecting a single colony, the Lactobacillus plantarum BFA-LA04 strain was further screened out therefrom. The Lactobacillus plantarum BFA-LA04 strain has been deposited in the NITE Patent Microorganisms Depository (...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com